MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/sla.0000000000001624

Медицинская библиотека · Annals of surgery · 2017

Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.

Leung Universe, Gönen Mithat, Allen Peter J, Kingham T Peter, DeMatteo Ronald P, Jarnagin William R, D'Angelica Michael I

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

The aim of the study was to evaluate outcomes after resection of colorectal liver metastases (CRLM) and concurrent extrahepatic disease (EHD), and to define prognostic factors.

BACKGROUND

There is increasing evidence to support resection of liver metastases and concurrent EHD in selected patients. Long-term survival data are lacking, and prognostic factors are not well defined.

METHODS

Retrospective review of 219 patients was undertaken between January 1992 and December 2012, who underwent hepatectomy for CRLM and resection of synchronous EHD. Survival outcomes were estimated by the Kaplan-Meier method. Univariate and multivariate analyses of prognostic factors were performed. A scoring system for prognostication was developed.

RESULTS

The median, 3, 5, and 10-year overall survival were 34.4 months, 49%, 28%, and 10%, respectively. Disease recurred in 185 patients (90.2%) at a median of 8 months. There were 8 actual 10-year survivors. The site of EHD affected survival, with portal, retroperitoneal nodes and multiple sites associated with the worst prognoses. The size of the largest CRLM, the number of CRLM, unfavorable site of EHD, and progression of CRLM on neoadjuvant therapy were associated with overall survival on univariate and multivariate analyses. Three variables, assigned 1 point each, were used to create an EHD risk score: largest CRLM greater than 3 cm, greater than 5 CRLM, and unfavorable site of EHD. The resulting score was prognostic of overall and recurrence-free survival.

CONCLUSIONS

Long-term survival is possible after resection of liver metastases and concurrent EHD, but true cure is rare. A proposed scoring system may identify patients most likely to benefit from surgery.

Для цитирования: Leung Universe, Gönen Mithat, Allen Peter J, Kingham T Peter, DeMatteo Ronald P, Jarnagin William R, D'Angelica Michael I. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.. Annals of surgery. 2017. DOI: 10.1097/sla.0000000000001624.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.